Viewing Study NCT05527418


Ignite Creation Date: 2025-12-25 @ 4:52 AM
Ignite Modification Date: 2026-02-06 @ 1:53 AM
Study NCT ID: NCT05527418
Status: RECRUITING
Last Update Posted: 2025-05-01
First Post: 2022-08-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerance and Antiretroviral Activity of Dasatinib: a Pilot Clinical Trial in Patients With Recent HIV-1 Infection
Sponsor: Eva Bonfill
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-01-26
Start Date Type: ACTUAL
Primary Completion Date: 2026-06
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-06
Completion Date Type: ESTIMATED
First Submit Date: 2022-08-03
First Submit QC Date: None
Study First Post Date: 2022-09-02
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-04-30
Last Update Post Date: 2025-05-01
Last Update Post Date Type: ACTUAL